164 related articles for article (PubMed ID: 30320429)
1. A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
Hoskins KF; Tejeda S; Vijayasiri G; Chukwudozie IB; Remo MH; Shah HA; Abraham IE; Balay LE; Maga TK; Searles ER; Korah VJ; Biggers A; Stolley MR; Warnecke RB
Cancer; 2018 Sep; 124(18):3733-3741. PubMed ID: 30320429
[TBL] [Abstract][Full Text] [Related]
2. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A
Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Bellcross CA; Leadbetter S; Alford SH; Peipins LA
Cancer Epidemiol Biomarkers Prev; 2013 Apr; 22(4):728-35. PubMed ID: 23371291
[TBL] [Abstract][Full Text] [Related]
4. Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.
Stuckey A; Febbraro T; Laprise J; Wilbur JS; Lopes V; Robison K
Am J Clin Oncol; 2016 Aug; 39(4):363-7. PubMed ID: 24710121
[TBL] [Abstract][Full Text] [Related]
5. Identifying Mediators of Intervention Effects Within a Randomized Controlled Trial to Motivate Cancer Genetic Risk Assessment Among Breast and Ovarian Cancer Survivors.
An J; Lu SE; McDougall J; Walters ST; Lin Y; Heidt E; Stroup A; Paddock L; Grumet S; Toppmeyer D; Kinney AY
Ann Behav Med; 2023 Oct; 57(11):965-977. PubMed ID: 37658805
[TBL] [Abstract][Full Text] [Related]
6. Embedding a genetic counselor into oncology clinics improves testing rates and timeliness for women with ovarian cancer.
Rana HQ; Kipnis L; Hehir K; Cronin A; Jaung T; Stokes SM; Fekrmandi F; Vatnick D; Matulonis UA; Garber JE; Wright AA
Gynecol Oncol; 2021 Feb; 160(2):457-463. PubMed ID: 33229043
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
8. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
9. Assessment of and Interventions for Women at High Risk for Breast or Ovarian Cancer: A Survey of Primary Care Physicians.
Samimi G; Heckman-Stoddard BM; Holmberg C; Tennant B; Sheppard BB; Coa KI; Kay SS; Ford LG; Szabo E; Minasian LM
Cancer Prev Res (Phila); 2021 Feb; 14(2):205-214. PubMed ID: 33023915
[TBL] [Abstract][Full Text] [Related]
10. Streamlining genetic testing for women with ovarian cancer in a Northern California health care system.
Powell CB; Laurent C; Ciaravino G; Garcia C; Han L; Hoodfar E; Karlea A; Kobelka C; Lee J; Littell RD; Roh J; Vay A; Kushi LH
Gynecol Oncol; 2020 Oct; 159(1):221-228. PubMed ID: 32778409
[TBL] [Abstract][Full Text] [Related]
11. Differences in referral patterns based on race for women at high-risk for ovarian cancer in the southeast: Results from a Gynecologic Cancer Risk Assessment Clinic.
Boitano TKL; Barrington DA; Batra S; McGwin G; Turner TB; Farmer MB; Brown AM; Straughn MJ; Leath CA
Gynecol Oncol; 2019 Aug; 154(2):379-382. PubMed ID: 31196574
[TBL] [Abstract][Full Text] [Related]
12. Impact of Implementing B-RST
Wernke K; Bellcross C; Gabram S; Ali N; Stanislaw C
Clin Breast Cancer; 2019 Aug; 19(4):e547-e555. PubMed ID: 31005475
[TBL] [Abstract][Full Text] [Related]
13. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
[No Abstract] [Full Text] [Related]
14. BRCA-Related Cancer Genetic Counseling is Indicated in Many Women Seeking Primary Care.
Parente DJ
J Am Board Fam Med; 2020; 33(6):885-893. PubMed ID: 33219067
[TBL] [Abstract][Full Text] [Related]
15. Attitudes, perceptions and practice of alcohol and drug screening, brief intervention and referral to treatment: a case study of New York State primary care physicians and non-physician providers.
Harris BR; Yu J
Public Health; 2016 Oct; 139():70-78. PubMed ID: 27311990
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.
Anderson EE; Tejeda S; Childers K; Stolley MR; Warnecke RB; Hoskins KF
J Oncol Pract; 2015 Jul; 11(4):e460-7. PubMed ID: 26036266
[TBL] [Abstract][Full Text] [Related]
17. Patterns of referral and uptake of BReast CAncer (BRCA) gene testing of eligible women with ovarian cancer in New Zealand.
Fraser K; Tan AL; Innes C; Stephens R; Tristram A; Petrich S; Lintott C; Sykes PH; Gamet K; Christian A; Simcock B
N Z Med J; 2019 Feb; 132(1490):26-35. PubMed ID: 30789886
[TBL] [Abstract][Full Text] [Related]
18. Improving Uptake of Cancer Genetic Risk Assessment in a Remote Tailored Risk Communication and Navigation Intervention: Large Effect Size but Room to Grow.
Kinney AY; Walters ST; Lin Y; Lu SE; Kim A; Ani J; Heidt E; Le Compte CJG; O'Malley D; Stroup A; Paddock LE; Grumet S; Boyce TW; Toppmeyer DL; McDougall JA
J Clin Oncol; 2023 May; 41(15):2767-2778. PubMed ID: 36787512
[TBL] [Abstract][Full Text] [Related]
19. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation.
Hull LE; Haas JS; Simon SR
Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717
[TBL] [Abstract][Full Text] [Related]
20. Implementing a Population-Based Breast Cancer Risk Assessment Program.
Silver E; Wenger N; Xie Z; Elashoff D; Lee K; Madlensky L; Trent J; Petruse A; Johansen L; Naeim A
Clin Breast Cancer; 2019 Aug; 19(4):246-253.e2. PubMed ID: 31072694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
